Günter Carl Hober
Managing Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references Quickcontact
Medical technology is used for various medical purposes in patients, including diagnosis, therapy, and surgery. It encompasses distinct segments within the healthcare industry, each characterized by its own technologies, intellectual property, trends, regulations, and market dynamics. The following specific applications of medical devices and technologies illustrate the complexity of these segments:
The more intimately an M&A advisor understands these niches, the more effectively they can guide the client through a transaction. Consequently, ConAlliance has established specialist teams dedicated to the distinct issues of specific medical technology segments and sectors. Our award-winning teams possess the requisite technological and regulatory expertise, maintain a robust global network, and are well-versed in the markets and current trends. Our specialization differentiates us as an M&A boutique, enabling us to ensure expert guidance, expedite mandate execution, and achieve optimal transaction outcomes.
The medical technology and medical device industry has always been attractive for M&A transactions.
Currently, mergers and acquisitions (M&A) in the medical technology and medical device sector are driven by the efforts of medium-sized companies to secure their strategic development and participate in technological innovations. Stakeholders are leveraging various opportunities, including partnerships with Asia and engagements from private equity firms, to maximize growth prospects and strengthen their market position. Pharmaceutical companies are seeking diversification and attempting to stabilize their portfolios through the acquisition of medical technology companies. These strategic moves are essential to remain competitive and meet the increasing demands for innovative medical technologies. Professionally guided company transactions, precise due diligence processes, and well-founded strategic planning are crucial for the success of such transactions.
From the perspective of mergers and acquisitions (M&A), the medical technology sector is heterogeneous due to its diverse range of products. The market is shaped not only by large players but also by small and medium-sized enterprises specializing in niche markets, resulting in significant differences in forecasts for individual medical products. The industry comprises numerous subsectors: Class I includes products like walking aids and bandages, Class IIa encompasses hearing aids, contact lenses, dental materials, and disinfectants, Class IIb covers anesthesia, ventilation, and radiation devices as well as blood bags, and Class III includes heart catheters, artificial joints, stents, and breast implants.
There are also substantial country-specific differences in production, sales, regulatory requirements, and approvals, consequently affecting the attractiveness for mergers and acquisitions.
In transaction consulting and transaction services, extensive expertise in relevant technologies, mechanical engineering, optical and acoustic procedures, electronics, as well as big data and artificial intelligence, forms the basis for analyzing and strategically advising on complex product portfolios. Additionally, the complex international regulations, approvals, and certifications of medical products, which can vary significantly by region, must be considered.
Through the specialists at ConAlliance, this can be ensured, and your acquisition or company sale can be successfully implemented. Feel free to contact us.
ConAlliance not only assists with corporate transactions but also prepares individual assessments, expert opinions and corresponding reports on medical technology companies or markets. This includes technological evaluation, strategic and competitive analysis and benchmarking, as well as market segment identification. Additionally, we identify attractive market segments and conduct market analyses, competitive analyses, customer analyses, and country analyses.
As deliverables, this includes critical subprocesses such as market studies, commercial due diligence reviews, financial due diligence reviews, and company valuations.
Moreover, we help our clients achieve improved results through business turnarounds and customized profitability enhancement projects.
ConAlliance possesses exceptional M&A expertise in the medical device and medical product sectors. This distinct proficiency differentiates us as a premier M&A advisory firm, ensuring our ability to deliver expert guidance and expedite the execution of our projects, ultimately achieving outstanding transaction outcomes.
ConAlliance serves M&A advice to medical products companies in all major geographies, including medical supplies, capital equipment, implantable devices, and others.
In developed markets, our experience working with leading payors, providers, and regulators allows us to provide a unique advice when selling or buying a medical device company.
ConAlliance provides strategic advice on a full range of medical device transactions, including:
The most important medical device manufacturers worldwide are (among others): Johnson and Johnson , Medtronic , GE Healthcare , Cardinal Health , Baxter International, Tyco Healthcare, Kodak Health Group , Hospira , Smith & Nephew , Boston Scientific , Stryker , B. Braun , St. Jude Medical , Guidant Corp., Siemens Medical Solutions , Philips Medical Systems , Fresenius , 3M Healthcare , Zimmer Holdings , Becton, Dickinson & Co. , Synthes , Alcon , Biomet , C. R. Bard , Terumo , Dentsply International , Invacare , Gambro , Dräger Medical , Varian Medical ,
the authorization of medical products for human use as well as the supervision of pharmaceutical companies are shared by different German authorities on the national and federal state level.
In M&A it is important is important to distinguish, i.e. medicinal products, medical products, medical devices, food products or cosmetics. The difference, for example, between medicinal products and medical devices is of great importance for the manufacturer, because medicinal products only can be marketed after a marketing authorization has been granted. Medical devices, for example, must undergo only a conformity-assessment procedure which is faster and less costly than medicinal product authorization.
ConAlliance Investmentbanking advises in acquiring medical product companies in Europe.
The reimbursability of the target’s products has a very significant financial impact on the deal.
M&A advisory services
m&a healthcare
ConAlliance healthcare investment banking and M&A services reach from medical technology, healthcare services, information-driven healthcare technology, life science tools and diagnostics to biopharmaceuticals and medical devices and pharmaceutical companies.
acquire medical device business
Our clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices.
ConAlliance is an German investment banking firm that focuses exclusively on the health care industry. Our clients include medical technology companies, pharmaceutical and biotech companies, health care information technology, private equity and venture capital. ConAlliance has one of the most experienced healthcare M&A teams in Germany with subsidiaries and offices in the USA and China and the most important countries in Europe. Operating out of offices in Germany, ConAlliance provides mergers & acquisitions, strategic and financial advisory solutions for its healthcare clients.
Within the life sciende industry our services comprise mergers and acquisitions, private placements, valuations and fairness opinions, distressed M&A, ....
ConAlliance is the leading European M&A advisory firm with respect to mergers acquisitions of medical devices.
m&a medical products mergers & acquisitions investmentbanking
sell medical device company
medical devices include heart implants and orthopedic implants, but that only begins to scratch the surface. Surgical equipment, radiological equipment, stretchers, wheelchairs, and hospital beds all fall under the medical device category. Basically, if you go into a hospital, anything that "do[es] not achieve its intended use through chemical reaction and [is] not metabolized in the body" is considered devices.
Mergers and acquisitions is a perfect tool for healthcare companies to stimulate inorganic growth – that means growth through licences, acquisitions and partnerships.
ConAlliance has a significant track record in completed transactions within the wound care sector. Our M&A advisors do not only know about investment banking, but also have deep insights into the wound care business. Wound care companies develop a full line of products to actively promote wound healing, maintain moist wound healing environment and control bacteria.
We are a longstanding leader in advising healthcare M&A transactions with special emphasis on medical devices.